Silverman v. Campbell was a South Carolina Supreme Court case regarding the
... Full case name, Herb Silverman v. Carol A. Campbell, et al. Argued, October ...
scholar.google.com/scholar_lookup?title=Coral reefs may start dissolving when atmospheric CO2 doubles&author=Silverman&publication_year=2009
Sep 18, 2014 ... The total infection rate ratio for TNF versus non-TNF group subjects ...
retrospective cohort studies by Beukelman et al. demonstrated that JIA ..... Lovell
DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. ... Listing
J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, et al.
Apr 21, 2015 ... Silverman E, Mouy R, Spiegel L, et al. Leflunomide ... Dziedziejko V, Kurzawski M
, Safranow K, et al. .... Strangfeld A, Hierse F, Kekow J, et al.
Aug 15, 2003 ... Katrin Strangfeld, ... which cleave various cellular substrates, thereby inducing
the demise of the cell (Los et al., 1999). .... although the protective effect was less
pronounced at high concentrations (1% v/v) of the bacterial supernatants. .....
lymphocytes (Weber et al., 2000; Goodyear and Silverman, 2003).
May 21, 2012 ... disease activity score (5.4 (4.7-6.5) in responders vs 4.9. (4.0-6.0) in non
responders, ..... Strangfeld A, Hierse F, Rau R, et al. Risk of incident or ... Dis
2007;66:1473–8. 17. Silverman GJ, Schwartzman S, Townsend M, et al.
May 21, 2012 ... RF-positivity (75.6% vs 66.7%, p=0.03 in univariate analysis) and anti-CCP
positivity (75.9% vs 62.2, p=0.001) were more frequent .... Strangfeld A,; Hierse F,
; Rau R,; et al .... Silverman GJ,; Schwartzman S,; Townsend M,; et al.
Jul 1, 2015 ... Silverman featuring research articles on clinical subjects from scientists working
is a monthly ... moderate/high disease activity at baseline exposed to ≥ 2 versus
1 prior anti-TNF was 0.40 (95% CI ... Harrold, et al: Real-world effectiveness of
RTX ...... Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F,.
Jun 1, 2014 ... an international journal edited by Earl D. Silverman ..... as outlined by Buch, et al,
should be taken into consideration when interpreting ... Efficacy and safety of
abatacept or infliximab vs placebo in ATTEST: a phase III, .... Listing J,; Strangfeld
A,; Kary S,; Rau R,; von Hinueber U,; Stoyanova-Scholz M,; et al.
www.rheumatology.org/Portals/0/Files/DSQ Summer 2012.pdf
versus the Population Rate from Package Insert or Registration RCTs*. Biologic.
Lymphoma SIR ..... 13. Strangfeld et al. Arthritis Res Therapy 2010, 12:R5. 14. Ji
J, et al. Rheumatology 2011 ..... Arabshahi B,. Silverman RA, et al. J Pediatr.